김범경
#간암#간질환
|
학력
2003.2 연세대학교 의과대학 졸업
2007.8 연세대학교 의과대학 대학원 석사학위 취득
2013.2 연세대학교 의과대학 대학원 박사학위 취득
2007.8 연세대학교 의과대학 대학원 석사학위 취득
2013.2 연세대학교 의과대학 대학원 박사학위 취득
경력
2003.3 - 2004.2 세브란스병원 인턴
2004.3 - 2008.2 세브란스병원 내과 전공의
2008.4 - 2011.4 군복무 (징병전담의사)
2011.5-2013.2 연세대학교 의과대학 세브란스병원 소화기내과 임상강사/임상연구조교수
2013.3.~ 현재 연세대학교 의과대학 세브란스병원 소화기내과 임상조교수/조교수/부교수
2004.3 - 2008.2 세브란스병원 내과 전공의
2008.4 - 2011.4 군복무 (징병전담의사)
2011.5-2013.2 연세대학교 의과대학 세브란스병원 소화기내과 임상강사/임상연구조교수
2013.3.~ 현재 연세대학교 의과대학 세브란스병원 소화기내과 임상조교수/조교수/부교수
논문
전신홍반루푸스에 의한 속발성 항인지질증후군에 동반된 정맥성 족부궤양 치험 1예
대한류마티스학회지 14/01 :71-77,2007
Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 137/4 :659-667,2011
Risk Assessment of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis by a Liver Stiffness Measurement-Based Model
AMERICAN JOURNAL OF GASTROENTEROLOGY 106/9 :1654-1662,2011
18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma
CANCER 117/0 :4779-4787,2011
"Normal" range of alanine aminotransferase levels for Asian population
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26/2 :219-220,2011
Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma
LIVER INTERNATIONAL 31/3 :369-376,2011
Gastroduodenal Complications After Concurrent Chemoradiation Therapy in Patients with Hepatocellular Carcinoma: Endoscopic Findings and Risk Factors.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 81/5 :1343-1351,2011
Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma
EUROPEAN JOURNAL OF CANCER 47/17 :2568-2575,2011
HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B
ANTIVIRAL THERAPY 16/8 :1169-1186,2011
Hepatitis B Virus Serology to Predict Antiviral Response in Chronic Hepatitis B
DIGESTION 84/ :29-34,2011
Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
ONCOLOGY 81/ :41-49,2011
Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
ALIMENTARY PHARMACOLOGY & THERAPEUTICS 35/11 :1343-1350,2012
Prospective validation of Fibrotest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B
PLOS ONE 7/4 :1-8,2012
Acute Variceal Hemorrhage in Patients with Liver Cirrhosis: Weekend versus Weekday Admissions
YONSEI MEDICAL JOURNAL 53/2 :318-327,2012
"Normal" liver stiffness values differ between men and women: A prospective study for healthy living liver and kidney donors in a native Korean population
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/4 :781-788,2012
Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: Single centre experience from long-term clinical outcomes of 1717 treatment-na?ve patients with hepatocellular carcinoma
LIVER INTERNATIONAL 32/7 :1120-1127,2012
Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
PLOS ONE 7/7 :-,2012
Prediction of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis Using the P2/MS Noninvasive Index Based on Complete Blood Counts.
DIGESTION 86/3 :264-272,2012
Risk Assessment of Development of Hepatic Decompensation in Histologically Proven Hepatitis B Viral Cirrhosis Using Liver Stiffness Measurement
DIGESTION 85/3 :219-227,2012
Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate.
ARTHRITIS RESEARCH & THERAPY 14/5 :R232-,2012
Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B
PLOS ONE 8/2 :e55759-e55759,2013
Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy
LIVER INTERNATIONAL 33/2 :180-189,2013
Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
EUROPEAN JOURNAL OF CANCER 49/4 :826-834,2013
Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 25/4 :514-515,2013
Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives
WORLD JOURNAL OF GASTROENTEROLOGY 19/12 :1890-1900,2013
Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea
LIVER INTERNATIONAL 33/5 :706-713,2013
Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization
CLINICAL CANCER RESEARCH 19/6 :1503-1511,2013
Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
PLOS ONE 8/10 :e77240-,2013
Clinical Application of Liver Stiffness Measurement Using Transient Elastography : A Surgical Perspective
DIGESTION 88/4 :258-265,2013
Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B
Clinical and Molecular Hepatology 19/1 :29-35,2013
Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker
PLOS ONE 9/1 :e86884-,2014
Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions
CLINICAL & EXPERIMENTAL METASTASIS 31/4 :475-482,2014
Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
PLOS ONE 9/6 :e98689-,2014
Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model
PLOS ONE 9/6 :e99167-,2014
Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigens
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/4 :843-850,2014
Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/5 :1005-1011,2014
Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir
LIVER INTERNATIONAL 34/8 :1216-1223,2014
Prediction of development of liver-related events by transient elastography in Hepatitis B patients with complete virological response on antiviral therapy
AMERICAN JOURNAL OF GASTROENTEROLOGY 109/8 :1241-1249,2014
Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/7 :1463-1469,2014
Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy
ANNALS OF SURGICAL ONCOLOGY 21/11 :3646-3653,2014
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naive chronic hepatitis B patients in Korea
Clinical and molecular hepatology 20/3 :261-266,2014
Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test
HEPATOLOGY 60/6 :1911-1919,2014
Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virologic response by pegylated interferon and ribavirin
DIGESTIVE DISEASES AND SCIENCES 60/2 :573-581,2015
Factors associated with significant liver fibrosis assessed using transient elastography in general population
WORLD JOURNAL OF GASTROENTEROLOGY 21/Issue :1158-1166,2015
Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: Considerations for tumor response assessment
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 9/3 :335-348,2015
Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma
ONCOTARGETS AND THERAPY 8/ :347-356,2015
Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea
DIGESTIVE DISEASES AND SCIENCES 60/1 :234-242,2015
Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B
LIVER INTERNATIONAL 35/2 :455-462,2015
A Novel Model to Predict Esophageal Varices in Patients with Compensated Cirrhosis Using Acoustic Radiation Force Impulse Elastography
PLOS ONE 10/3 :e0121009-,2015
Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients With Transient Elastography-Defined Subclinical Cirrhosis
HEPATOLOGY 61/6 :1851-1859,2015
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma
JOURNAL OF HEPATOLOGY 62/6 :1304-1310,2015
Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization
LIVER INTERNATIONAL 35/6 :1722-1730,2015
Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization
DIGESTIVE AND LIVER DISEASE 47/8 :682-688,2015
Disease duration and Medsger’s severity score are associated with significant liver fibrosis in patients with systemic sclerosis
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Suppl. 91 :S68-S74,2015
Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 30/10 :1536-1542,2015
Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma
YONSEI MEDICAL JOURNAL 56/5 :1296-1306,2015
Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance
PLOS ONE 10/8 :1-17,2015
Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography
PLOS ONE 10/9 :e0139227-,2015
Factors that affect visibility during endoscopic hemostasis for upper GI bleeding: a prospective study
GASTROINTESTINAL ENDOSCOPY 81/6 :1392-1400,2015
Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
GUT AND LIVER 9/6 :776-783,2015
Validation of Hepatitis B Virus-Related Hepatocellular Carcinoma Prediction Models in the Era of Antiviral Therapy
HEPATOLOGY 62/6 :1757-1766,2015
Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis
LIVER INTERNATIONAL 35/3 :1054-1062,2015
Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51/3 :344-353,2016
Outcome of adefovir add-on lamivudine rescue therapy of up to 5?years in patients with lamivudine-resistant chronic hepatitis B.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/1 :241-247,2016
Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score
LIVER INTERNATIONAL 36/1 :100-107,2016
Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B
LIVER INTERNATIONAL 36/1 :24-30,2016
Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model.
LIVER INTERNATIONAL 36/1 :92-99,2016
Factors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B
GUT AND LIVER 10/2 :275-282,2016
Prediction of Virologic Response to Tenofovir Mono-Rescue Therapy for Multidrug Resistant Chronic Hepatitis B
JOURNAL OF MEDICAL VIROLOGY 88/6 :1027-1034,2016
Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus
MEDICINE 95/14 :e3328-,2016
Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
GUT AND LIVER 10/3 :429-436,2016
Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/4 :842-847,2016
Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
MEDICINE 95/20 :e3434-,2016
Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome.
MODERN RHEUMATOLOGY 26/4 :576-582,2016
Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51/5 :618-624,2016
Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients
JOURNAL OF GASTROENTEROLOGY 51/8 :830-839,2016
Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C
JOURNAL OF KOREAN MEDICAL SCIENCE 31/9 :1,431-1,437,2016
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Clinical and molecular hepatology 22/4 :443-449,2016
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 14/11 :1,647-1,647,2016
Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy
JOURNAL OF MEDICAL VIROLOGY 89/1 :85-90,2017
Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
JOURNAL OF VIRAL HEPATITIS 24/2 :141-147,2017
Conventional versus drug-eluting beads chemoembolization for hpeatocellular carcinoma: Emphasis on the impact of tumor size
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/2 :487-496,2017
Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization
HEPATOLOGY INTERNATIONAL 11/3 :292-299,2017
Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis
AMERICAN JOURNAL OF GASTROENTEROLOGY 112/6 :882-891,2017
Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis
HEPATOLOGY INTERNATIONAL 11/3 :268-276,2017
Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke
ATHEROSCLEROSIS 260/ :156-162,2017
Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/6 :1,221-1,229,2017
Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/5 :1,079-1,086,2017
Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 99/2 :396-406,2017
Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development
LIVER INTERNATIONAL 37/6 :879-887,2017
Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
ONCOTARGET 8/45 :79,914-79,926,2017
Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway
ONCOTARGET 8/35 :58,974-58,984,2017
Current status and strategies for hepatitis C control in South Korea
Clinical and molecular hepatology 23/3 :212-218,2017
Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
GUT AND LIVER 11/6 :828-834,2017
Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation
GUT AND LIVER 11/5 :693-701,2017
Validation of the PAGE-B Model in Asian Chronic Hepatitis B Patients Receiving Entecavir or Tenofovir
LIVER INTERNATIONAL 37/12 :1788-1795,2017
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease
DIGESTIVE DISEASES AND SCIENCES 62/8 :2,150-2,158,2017
Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
GUT AND LIVER 12/2 :190-200,2018
Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance
JOURNAL OF MEDICAL VIROLOGY 90/3 :497-502,2018
Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance
ALIMENTARY PHARMACOLOGY & THERAPEUTICS 47/8 :1,201-1,212,2018
Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
GUT AND LIVER 12/3 :324-330,2018
Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
LIVER INTERNATIONAL 38/4 :676-686,2018
Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B
ALIMENTARY PHARMACOLOGY & THERAPEUTICS 48/3 :300-312,2018
Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib
LIVER INTERNATIONAL 38/9 :1,655-1,663,2018
Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients
CEREBROVASCULAR DISEASES 47/1-2 :32-39,2019
Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers
LIVER INTERNATIONAL 39/1 :81-89,2019
Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
SCIENTIFIC REPORTS 9/1 :2,508-,2019
Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
Journal of Clinical Medicine 7/8 :3-,2019
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
PLOS ONE 14/4 :e0214613-,2019
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
BMC CANCER 19/363 :-,2019
Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model
GUT AND LIVER 13/2 :206-214,2019
Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
GUT AND LIVER 13/2 :197-205,2019
Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals
Clinical and Translational Gastroenterology 10/6 :e00036-,2019
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Cancers 11/4 :E509-,2019
Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY 30/8 :1,194-1,200,2019
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea
JOURNAL OF HEPATOLOGY 71/3 :456-464,2019
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
CANCER MEDICINE 8/11 :5,023-5,032,2019
Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
PLOS ONE 14/10 :e0223678-,2019
External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy
LIVER INTERNATIONAL 39/9 :1,624-1,630,2019
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
Clinical and molecular hepatology 25/3 :283-293,2019
Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 17/7 :1,348-1355.e2,2019
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 54/10 :1,283-1,290,2019
김범경
대한류마티스학회지 14/01 :71-77,2007
Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 137/4 :659-667,2011
Risk Assessment of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis by a Liver Stiffness Measurement-Based Model
AMERICAN JOURNAL OF GASTROENTEROLOGY 106/9 :1654-1662,2011
18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma
CANCER 117/0 :4779-4787,2011
"Normal" range of alanine aminotransferase levels for Asian population
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26/2 :219-220,2011
Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma
LIVER INTERNATIONAL 31/3 :369-376,2011
Gastroduodenal Complications After Concurrent Chemoradiation Therapy in Patients with Hepatocellular Carcinoma: Endoscopic Findings and Risk Factors.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 81/5 :1343-1351,2011
Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma
EUROPEAN JOURNAL OF CANCER 47/17 :2568-2575,2011
HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B
ANTIVIRAL THERAPY 16/8 :1169-1186,2011
Hepatitis B Virus Serology to Predict Antiviral Response in Chronic Hepatitis B
DIGESTION 84/ :29-34,2011
Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
ONCOLOGY 81/ :41-49,2011
Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma
ALIMENTARY PHARMACOLOGY & THERAPEUTICS 35/11 :1343-1350,2012
Prospective validation of Fibrotest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B
PLOS ONE 7/4 :1-8,2012
Acute Variceal Hemorrhage in Patients with Liver Cirrhosis: Weekend versus Weekday Admissions
YONSEI MEDICAL JOURNAL 53/2 :318-327,2012
"Normal" liver stiffness values differ between men and women: A prospective study for healthy living liver and kidney donors in a native Korean population
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/4 :781-788,2012
Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: Single centre experience from long-term clinical outcomes of 1717 treatment-na?ve patients with hepatocellular carcinoma
LIVER INTERNATIONAL 32/7 :1120-1127,2012
Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
PLOS ONE 7/7 :-,2012
Prediction of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis Using the P2/MS Noninvasive Index Based on Complete Blood Counts.
DIGESTION 86/3 :264-272,2012
Risk Assessment of Development of Hepatic Decompensation in Histologically Proven Hepatitis B Viral Cirrhosis Using Liver Stiffness Measurement
DIGESTION 85/3 :219-227,2012
Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate.
ARTHRITIS RESEARCH & THERAPY 14/5 :R232-,2012
Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B
PLOS ONE 8/2 :e55759-e55759,2013
Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy
LIVER INTERNATIONAL 33/2 :180-189,2013
Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
EUROPEAN JOURNAL OF CANCER 49/4 :826-834,2013
Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 25/4 :514-515,2013
Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives
WORLD JOURNAL OF GASTROENTEROLOGY 19/12 :1890-1900,2013
Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea
LIVER INTERNATIONAL 33/5 :706-713,2013
Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization
CLINICAL CANCER RESEARCH 19/6 :1503-1511,2013
Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
PLOS ONE 8/10 :e77240-,2013
Clinical Application of Liver Stiffness Measurement Using Transient Elastography : A Surgical Perspective
DIGESTION 88/4 :258-265,2013
Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B
Clinical and Molecular Hepatology 19/1 :29-35,2013
Use of the Delta Neutrophil Index as a Prognostic Factor of Mortality in Patients with Spontaneous Bacterial Peritonitis: Implications of a Simple and Useful Marker
PLOS ONE 9/1 :e86884-,2014
Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions
CLINICAL & EXPERIMENTAL METASTASIS 31/4 :475-482,2014
Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
PLOS ONE 9/6 :e98689-,2014
Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model
PLOS ONE 9/6 :e99167-,2014
Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigens
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/4 :843-850,2014
Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/5 :1005-1011,2014
Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir
LIVER INTERNATIONAL 34/8 :1216-1223,2014
Prediction of development of liver-related events by transient elastography in Hepatitis B patients with complete virological response on antiviral therapy
AMERICAN JOURNAL OF GASTROENTEROLOGY 109/8 :1241-1249,2014
Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: A Korean multicenter study
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/7 :1463-1469,2014
Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy
ANNALS OF SURGICAL ONCOLOGY 21/11 :3646-3653,2014
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naive chronic hepatitis B patients in Korea
Clinical and molecular hepatology 20/3 :261-266,2014
Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test
HEPATOLOGY 60/6 :1911-1919,2014
Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virologic response by pegylated interferon and ribavirin
DIGESTIVE DISEASES AND SCIENCES 60/2 :573-581,2015
Factors associated with significant liver fibrosis assessed using transient elastography in general population
WORLD JOURNAL OF GASTROENTEROLOGY 21/Issue :1158-1166,2015
Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: Considerations for tumor response assessment
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 9/3 :335-348,2015
Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma
ONCOTARGETS AND THERAPY 8/ :347-356,2015
Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea
DIGESTIVE DISEASES AND SCIENCES 60/1 :234-242,2015
Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B
LIVER INTERNATIONAL 35/2 :455-462,2015
A Novel Model to Predict Esophageal Varices in Patients with Compensated Cirrhosis Using Acoustic Radiation Force Impulse Elastography
PLOS ONE 10/3 :e0121009-,2015
Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients With Transient Elastography-Defined Subclinical Cirrhosis
HEPATOLOGY 61/6 :1851-1859,2015
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma
JOURNAL OF HEPATOLOGY 62/6 :1304-1310,2015
Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization
LIVER INTERNATIONAL 35/6 :1722-1730,2015
Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization
DIGESTIVE AND LIVER DISEASE 47/8 :682-688,2015
Disease duration and Medsger’s severity score are associated with significant liver fibrosis in patients with systemic sclerosis
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Suppl. 91 :S68-S74,2015
Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 30/10 :1536-1542,2015
Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma
YONSEI MEDICAL JOURNAL 56/5 :1296-1306,2015
Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance
PLOS ONE 10/8 :1-17,2015
Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography
PLOS ONE 10/9 :e0139227-,2015
Factors that affect visibility during endoscopic hemostasis for upper GI bleeding: a prospective study
GASTROINTESTINAL ENDOSCOPY 81/6 :1392-1400,2015
Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
GUT AND LIVER 9/6 :776-783,2015
Validation of Hepatitis B Virus-Related Hepatocellular Carcinoma Prediction Models in the Era of Antiviral Therapy
HEPATOLOGY 62/6 :1757-1766,2015
Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis
LIVER INTERNATIONAL 35/3 :1054-1062,2015
Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51/3 :344-353,2016
Outcome of adefovir add-on lamivudine rescue therapy of up to 5?years in patients with lamivudine-resistant chronic hepatitis B.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/1 :241-247,2016
Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score
LIVER INTERNATIONAL 36/1 :100-107,2016
Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B
LIVER INTERNATIONAL 36/1 :24-30,2016
Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model.
LIVER INTERNATIONAL 36/1 :92-99,2016
Factors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B
GUT AND LIVER 10/2 :275-282,2016
Prediction of Virologic Response to Tenofovir Mono-Rescue Therapy for Multidrug Resistant Chronic Hepatitis B
JOURNAL OF MEDICAL VIROLOGY 88/6 :1027-1034,2016
Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus
MEDICINE 95/14 :e3328-,2016
Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
GUT AND LIVER 10/3 :429-436,2016
Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/4 :842-847,2016
Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
MEDICINE 95/20 :e3434-,2016
Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome.
MODERN RHEUMATOLOGY 26/4 :576-582,2016
Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51/5 :618-624,2016
Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients
JOURNAL OF GASTROENTEROLOGY 51/8 :830-839,2016
Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C
JOURNAL OF KOREAN MEDICAL SCIENCE 31/9 :1,431-1,437,2016
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Clinical and molecular hepatology 22/4 :443-449,2016
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 14/11 :1,647-1,647,2016
Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy
JOURNAL OF MEDICAL VIROLOGY 89/1 :85-90,2017
Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
JOURNAL OF VIRAL HEPATITIS 24/2 :141-147,2017
Conventional versus drug-eluting beads chemoembolization for hpeatocellular carcinoma: Emphasis on the impact of tumor size
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/2 :487-496,2017
Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization
HEPATOLOGY INTERNATIONAL 11/3 :292-299,2017
Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis
AMERICAN JOURNAL OF GASTROENTEROLOGY 112/6 :882-891,2017
Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis
HEPATOLOGY INTERNATIONAL 11/3 :268-276,2017
Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke
ATHEROSCLEROSIS 260/ :156-162,2017
Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/6 :1,221-1,229,2017
Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/5 :1,079-1,086,2017
Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 99/2 :396-406,2017
Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development
LIVER INTERNATIONAL 37/6 :879-887,2017
Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
ONCOTARGET 8/45 :79,914-79,926,2017
Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway
ONCOTARGET 8/35 :58,974-58,984,2017
Current status and strategies for hepatitis C control in South Korea
Clinical and molecular hepatology 23/3 :212-218,2017
Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
GUT AND LIVER 11/6 :828-834,2017
Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation
GUT AND LIVER 11/5 :693-701,2017
Validation of the PAGE-B Model in Asian Chronic Hepatitis B Patients Receiving Entecavir or Tenofovir
LIVER INTERNATIONAL 37/12 :1788-1795,2017
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease
DIGESTIVE DISEASES AND SCIENCES 62/8 :2,150-2,158,2017
Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
GUT AND LIVER 12/2 :190-200,2018
Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance
JOURNAL OF MEDICAL VIROLOGY 90/3 :497-502,2018
Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance
ALIMENTARY PHARMACOLOGY & THERAPEUTICS 47/8 :1,201-1,212,2018
Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
GUT AND LIVER 12/3 :324-330,2018
Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
LIVER INTERNATIONAL 38/4 :676-686,2018
Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B
ALIMENTARY PHARMACOLOGY & THERAPEUTICS 48/3 :300-312,2018
Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib
LIVER INTERNATIONAL 38/9 :1,655-1,663,2018
Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients
CEREBROVASCULAR DISEASES 47/1-2 :32-39,2019
Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers
LIVER INTERNATIONAL 39/1 :81-89,2019
Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
SCIENTIFIC REPORTS 9/1 :2,508-,2019
Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
Journal of Clinical Medicine 7/8 :3-,2019
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
PLOS ONE 14/4 :e0214613-,2019
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
BMC CANCER 19/363 :-,2019
Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model
GUT AND LIVER 13/2 :206-214,2019
Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
GUT AND LIVER 13/2 :197-205,2019
Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals
Clinical and Translational Gastroenterology 10/6 :e00036-,2019
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Cancers 11/4 :E509-,2019
Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY 30/8 :1,194-1,200,2019
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea
JOURNAL OF HEPATOLOGY 71/3 :456-464,2019
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
CANCER MEDICINE 8/11 :5,023-5,032,2019
Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
PLOS ONE 14/10 :e0223678-,2019
External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy
LIVER INTERNATIONAL 39/9 :1,624-1,630,2019
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
Clinical and molecular hepatology 25/3 :283-293,2019
Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 17/7 :1,348-1355.e2,2019
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 54/10 :1,283-1,290,2019
김범경
저서
저서 내용이 없습니다.
보도자료
[연합뉴스TV] 음복 한 잔에 기름진 명절음식…간질환에는 복 아닌 독 - ...
http://www.yonhapnewstv.co.kr/MYH20190206003000038/?did=1825m
[서울신문] [메디컬 인사이드] 간암 환자 30%는 술 때문이야… ‘술푼 ...
http://www.seoul.co.kr/news/newsView.php?id=20180820023002&wlog_tag3=naver
[경향신문] 아산의학상 젊은 의학자 부문 수상 - 소화기내과 김범경 교수
http://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=102&oid=032&aid=0002843439
http://www.yonhapnewstv.co.kr/MYH20190206003000038/?did=1825m
[서울신문] [메디컬 인사이드] 간암 환자 30%는 술 때문이야… ‘술푼 ...
http://www.seoul.co.kr/news/newsView.php?id=20180820023002&wlog_tag3=naver
[경향신문] 아산의학상 젊은 의학자 부문 수상 - 소화기내과 김범경 교수
http://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=102&oid=032&aid=0002843439
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.